We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+9.53%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.36B
AUM Growth
+$77.6M
Cap. Flow
+$46.1M
Cap. Flow %
3.39%
Top 10 Hldgs %
13.88%
Holding
1,633
New
514
Increased
325
Reduced
386
Closed
373

Top Buys

Rank Stock Value
1
NICE icon
Nice
NICE
+$14.2M
2
DOMO icon
Domo
DOMO
+$12.7M
3
NFLX icon
Netflix
NFLX
+$12.4M
4
EA
Electronic Arts
EA
+$12.3M
5
DAY
Dayforce
DAY
+$11.5M

Top Sells

Rank Stock Value
1
VRNA
Verona Pharma
VRNA
+$17.1M
2
COOP
Mr. Cooper
COOP
+$13.5M
3
K
Kellanova
K
+$11.9M
4
LITE icon
Lumentum
LITE
+$9.69M
5
IBIT icon
iShares Bitcoin Trust
IBIT
+$9.44M

Sector Composition

Rank Sector Weight
1 Technology 23.27%
2 Healthcare 13.54%
3 Communication Services 10.55%
4 Consumer Discretionary 9.61%
5 Industrials 9.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VTYX
1576
DELISTED
Ventyx Biosciences
VTYX
-21,200
Closed -$65.9K
WBS icon
1577
Webster Financial
WBS
$12.8B
-17,701
Closed -$1.05M
WFC icon
1578
Wells Fargo
WFC
$264B
-15,498
Closed -$1.3M
WH icon
1579
Wyndham Hotels & Resorts
WH
$5.48B
-5,526
Closed -$442K
WIX icon
1580
WIX.com
WIX
$2.52B
-2,011
Closed -$357K
WLDN icon
1581
Willdan Group
WLDN
$1.3B
-3,605
Closed -$349K
WMB icon
1582
Williams Companies
WMB
$86.1B
-3,964
Closed -$251K
WNS
1583
DELISTED
WNS Holdings
WNS
-86,612
Closed -$6.61M
WU icon
1584
Western Union
WU
$2.21B
-20,480
Closed -$164K
WULF icon
1585
CALL
TeraWulf
WULF
$8.52B
-2,300
Closed -$207K
XERS icon
1586
Xeris Biopharma Holdings
XERS
$1.45B
-15,500
Closed -$126K
XLE icon
1587
State Street Energy Select Sector SPDR ETF
XLE
$37.6B
-9,136
Closed -$408K
XLU icon
1588
State Street Utilities Select Sector SPDR ETF
XLU
$22.7B
-6,044
Closed -$264K
XME icon
1589
State Street SPDR S&P Metals & Mining ETF
XME
$4.48B
-2,750
Closed -$256K
XNCR icon
1590
Xencor
XNCR
$1.55B
-11,880
Closed -$139K
XOM icon
1591
ExxonMobil
XOM
$634B
-3,108
Closed -$350K
XPRO icon
1592
Expro Ltd
XPRO
$1.91B
-45,509
Closed -$541K
XYL icon
1593
Xylem
XYL
$28.1B
-2,230
Closed -$329K
YMM icon
1594
Full Truck Alliance
YMM
$9.99B
-92,971
Closed -$1.21M
ZBRA icon
1595
Zebra Technologies
ZBRA
$17.8B
-677
Closed -$201K
ZIMV
1596
DELISTED
ZimVie
ZIMV
-44,670
Closed -$846K
ZION icon
1597
Zions Bancorporation
ZION
$10.3B
-4,083
Closed -$231K
BTSG icon
1598
BrightSpring Health Services
BTSG
$12.4B
-13,042
Closed -$386K
ANRO icon
1599
Alto Neuroscience
ANRO
$1.11B
-11,401
Closed -$45.8K
KYTX icon
1600
Kyverna Therapeutics
KYTX
$484M
-19,438
Closed -$117K

Similar funds

Prelude Capital Management's Q4 2025 Portfolio in Review

As of Q4 2025, Prelude Capital Management held 1,633 positions worth $1.36B, up 6.1% from $1.28B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Prelude Capital Management deployed $46.1M of net new capital in Q4 2025, opening 514 new positions and adding to 325 existing holdings. Its largest new stake was Nice: 117,600 shares worth $13.3M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Healthcare and Communication Services.

On the sell side, the largest reduction was Lumentum, an estimated $9.69M trimmed.

  • Prelude Capital Management's largest Q4 2025 buy was Nice: 117,600 shares worth $13.3M.
  • Prelude Capital Management added most to Domo in Q4 2025, an estimated $12.7M increase.
  • Prelude Capital Management's biggest Q4 2025 reduction was Lumentum, cutting an estimated $9.69M.
  • Prelude Capital Management fully exited Verona Pharma in Q4 2025, selling an estimated $17.1M.
  • Prelude Capital Management's ten largest holdings make up 14% of its $1.36B portfolio in Q4 2025.
  • Prelude Capital Management opened 514 new positions and closed 373 in Q4 2025.
  • Prelude Capital Management's portfolio value rose 6.1% quarter-over-quarter to $1.36B.

Based on Prelude Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.